Yonhap Infomax NewsApr 18, 2025
Daewoong Pharmaceutical's diabetes drug Envlo expands global reach with approval submissions in 7 new countries, aiming for 30-country market presence by 2030
#YonhapInfomax #DaewoongPharmaceutical #Envlo #DiabetesTreatment #GlobalExpansion #SGLT2Inhibitor #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=59314
Daewoong Pharmaceutical's Diabetes Drug 'Envlo' Submitted for Approval in 7 Countries Including Latin America and Russia

Daewoong Pharmaceutical's diabetes drug Envlo expands global reach with approval submissions in 7 new countries, aiming for 30-country market presence by 2030

Yonhap Infomax